[1]
Sharma, V., Chawla, S., Garg, S. and Singh, B. 2024. Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus: An open-label comparative study. Sultan Qaboos University Medical Journal. 24, 2 (May 2024), 243–249. DOI:https://doi.org/10.18295/squmj.1.2024.006.